The company is now ready to offer clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours
The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.
Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively
Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
_256_384.jpg)
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The programme will be implemented across 13 states and benefit 256 min
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Subscribe To Our Newsletter & Stay Updated
